Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Eql Pharma Int AB
AB
Active
Org 5569579484
Stortorget 1, 222 23
Lund
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2014 · 12 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Eql Pharma Int AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
3M
5M
7M
5M
2021
4M
2022
6M
2023
6M
2024
3M
2025
EBITDA
SEK millions
3M
2M
1M
1M
0M
1M
2021
0M
-100%
2022
0M
0%
2023
2M
+200%
2024
2M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
5 197
3 704
5 580
6 001
3 219
Staff expenses
—
—
—
—
—
EBITDA
631
372
161
1 561
1 763
Depreciation & amort.
−155
−44
−0
−0
−1 611
EBIT
476
328
161
1 561
152
Net financials
—
—
−3
—
1
Profit before tax
477
8
8
11
153
Tax
−55
−2
−2
−2
−32
Net profit
422
6
6
9
121
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 794
2 861
3 702
2 973
192 695
Equity
826
832
838
847
968
Long-term debt
2 407
1 487
2 226
1 550
191 215
Short-term debt
561
542
638
576
512
Total debt
2 968
2 029
2 864
2 126
191 727
Financial ratios
5-year trend
EBITDA-margin
54.8%
This company
15.8%
Market median
+247% vs market
2021
2025
Soliditetsgrad
0.5%
This company
38.2%
Market median
-99% vs market
2021
2025
Egenkapitalforrentning
12.5%
This company
18.4%
Market median
+32% vs market
2021
2025
Nettoresultatgrad
3.8%
This company
8.1%
Market median
-53% vs market
2021
2025
Aktivomsætning
0.02×
This company
1.12×
Market median
-98% vs market
2021
2025
Gæld/egenkapital
198.07×
This company
0.62×
Market median
-31847% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
More on Eql Pharma Int AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
